Note 9 - Stockholders' Deficit (Details 2) - USD ($) |
12 Months Ended | |
|---|---|---|
Jun. 30, 2019 |
Jun. 30, 2018 |
|
| Allocated share-based compensation expense | $ 1,944,000 | $ 255,000 |
| Research and Development Expense | ||
| Allocated share-based compensation expense | 314,000 | 96,000 |
| General and Administrative Expense | ||
| Allocated share-based compensation expense | $ 1,630,000 | $ 159,000 |
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|